450
Participants
Start Date
October 31, 2006
Primary Completion Date
October 31, 2030
Study Completion Date
October 31, 2030
Observation
No interventions planned: treatment of patients at the discretion of the treating/responsible physician
RECRUITING
University Clinic of Hematology and Central Hematology Laboratory, Bern University Hospital and the University of Bern, Inselspital, Bern
RECRUITING
University of Oklahoma Health Sciences Center, Department of Medicine, PO Box 26901, Oklahoma City
RECRUITING
Medical University of Vienna, Department of Medicine 1, Div. Hematology and Hemostasis Waehringer Guertel 18-20, Vienna
RECRUITING
Institute of Hematology and Blood Transfusion, Coagulation Laboratory, U nemocnice 1, Prague
NOT_YET_RECRUITING
University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Martinistr 52, Hamburg
RECRUITING
Nara Medical University, Department of Blood Transfusion Medicine, Shijyo-cho 840, Kashihara
RECRUITING
Trondheim University St Olavs Hospital, Department of Hematology, PO Box 3250 Sluppen, Trondheim
Swiss National Science Foundation
OTHER
Mach Gaensslen Foundation
OTHER
Baxalta Innovations GmbH, Wien, Austria
UNKNOWN
Insel Gruppe AG, University Hospital Bern
OTHER